The FDA’s approval of Aducanumab this week marked the first new treatment for Alzheimer’s in 20 years.
Get up to speed on what it does and what the development means.
'This is not a cure' -doctor on Alzheimer's drug
Reuters - Politics
Sixty-nine year-old runner and Alzheimer's patient Bill McKay hopes the new Biogen drug will get his life back on track, but his..
